Friday, July 31, 2009

Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis

›
This study is currently recruiting participants. Verified by National Institutes of Health Clinical Center (CC), July 2009 First Received: J...
Thursday, July 30, 2009

Scientists discover why we never forget how to ride a bicycle

›
PhysOrg.com, July 17th, 2009 Their research, published this month in Nature Neuroscience, has identified a key nerve cell in the brain that ...
Wednesday, July 29, 2009

Structural basis for the mechanism of respiratory complex I.

›
J Biol Chem. 2009 Jul 27. Berrisford JM , Sazanov LA . Medical Research Council, United Kingdom. Keywords: Cellular energy production...
Tuesday, July 28, 2009

Stress signals link pre-existing sickness with susceptibility to bacterial infection

›
Bio-Medicine, Date:7/28/2009 Mitochondrial diseases disrupt the power generating machinery within cells and increase a person's suscepti...
Friday, July 24, 2009

The First Cellular Models Based on Frataxin Missense Mutations That Reproduce Spontaneously the Defects Associated with Friedreich Ataxia

›
Open-access -Creative Commons Attribution License Full text PLoS One. 2009; 4(7): e6379. Published online 2009 July 24. doi: 10.1371/journal...
Thursday, July 23, 2009

Human ISD11 is essential for both iron–sulfur cluster assembly and maintenance of normal cellular iron homeostasis

›
Human Molecular Genetics Advance Access originally published online on May 18, 2009 Human Molecular...
Wednesday, July 22, 2009

Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease (FAIR-PARK-I)

›
Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease (FAIR-PARK-I) This study is not yet open for participant rec...
Tuesday, July 21, 2009

Transplanted Neurons Develop Disease-like Pathology In Huntington's Patients

›
ScienceDaily (July 20, 2009) — The results of a recent study published in the Proceedings of the National Academy of Sciences question the l...
Thursday, July 16, 2009

Penwest Announces Results of Phase Ib Trial of A0001

›
GlobeNewswire Source: Penwest Pharmaceuticals Co. In the Phase Ib trial, the drug was well tolerated by subjects, and no serious adverse eve...

UA Professors receive over $1.45 million in grants

›
Money to fund researching neurological diseases The Crimson White, Published: Thursday, July 16, 2009 .../... While they are researching di...